Vontobel Holding Ltd. Trevi Therapeutics, Inc. Transaction History
Vontobel Holding Ltd.
- $25.5 Billion
- Q1 2025
A detailed history of Vontobel Holding Ltd. transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 31,359 shares of TRVI stock, worth $215,749. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,359Holding current value
$215,749% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TRVI
# of Institutions
120Shares Held
77.6MCall Options Held
218KPut Options Held
182K-
Nea Management Company, LLC Timonium, MD11.4MShares$78.2 Million3.46% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.7MShares$73.4 Million2.72% of portfolio
-
Viking Global Investors LP4.4MShares$30.3 Million0.06% of portfolio
-
Rubric Capital Management LP New York, NY4.21MShares$28.9 Million0.3% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.15MShares$28.6 Million0.04% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $401M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...